• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS25
Device Problems Difficult to Fold, Unfold or Collapse (1254); Perivalvular Leak (1457)
Patient Problem No Information (3190)
Event Date 11/28/2018
Event Type  Injury  
Event Description
A perceval pvs25 was implanted on (b)(6) 2018.It was reported that the surgeon had some difficulty collapsing the valve.After several tries to collapse the valve, the valve looked imperfect on the holder and the stent was reportedly not symmetrical.The valve was implanted, and the visual aspect then appeared correct.It was stated that after decannulation, while the patient was in icu, a leak was identified.Re-operation was performed and the valve was explanted and replaced with a trifecta valve (size unknown).It was reported that there was a "crimping defect" of the valve; however, it could not be confirmed that the valve was folded at the time of re-operation.It was reported that the valve may not have been correctly implanted in the annulus.
 
Manufacturer Narrative
A complete review of the manufacturing and quality control data filed in the device history record of the perceval heart valve prosthesis, pvs 25/l, sn (b)(4), confirmed that the valve satisfied all material, dimensional and performance standards required for a size 25/l perceval heart valve at the time of manufacture and release.The valve was received in non-standard packaging conditions in a dry, under-sized jar.The pericardium was darkened and slightly dehydrated, although the leaflets were pliable.Visual inspection of the returned device, although partly dehydrated, did not reveal any anomalies attributable to pre-existing manufacturing defects.An attempt was made to simulate the reported issue; however, the dehydrated state of the returned device rendered the simulation of the reported event impossible.Due to the deeply altered state of the valve, an exhaustive investigation of the reported event could not be performed and the root cause of the event cannot be established.However, based on the document review performed, no manufacturing deficiencies were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L.
strada crescentino snc
saluggia, vc
MDR Report Key8182192
MDR Text Key130991723
Report Number3005687633-2018-00236
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 02/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/19/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/10/2022
Device Model NumberPVS25
Device Catalogue NumberICV1210
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/31/2019
Was the Report Sent to FDA? No
Date Manufacturer Received01/22/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-